Comerica Bank Standard Biotools Inc. Transaction History
Comerica Bank
- $24.4 Billion
- Q4 2024
A detailed history of Comerica Bank transactions in Standard Biotools Inc. stock. As of the latest transaction made, Comerica Bank holds 2,056 shares of LAB stock, worth $2,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,056
Previous 2,413
14.79%
Holding current value
$2,734
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LAB
# of Institutions
143Shares Held
270MCall Options Held
27.2KPut Options Held
14.1K-
Casdin Capital, LLC New York, NY71.3MShares$94.8 Million10.73% of portfolio
-
Viking Global Investors LP58.7MShares$78 Million0.35% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$22.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY16.9MShares$22.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $105M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...